Part 54 — Financial Disclosure by Clinical Investigators

Authority: 21 U.S.C. 321, 331, 351, 352, 353, 355, 360, 360c-360j, 371, 372, 373, 374, 375, 376, 379; 42 U.S.C. 262.

Source: 63 FR 5250, Feb. 2, 1998, unless otherwise noted.